The study, conducted in the department of internal medicine, PGIMER, is the first clinical study to demonstrate the ...
Signed during the ISPOR UAE Chapter 2026 Conference in Abu Dhabi, the Memorandum of Understanding (MoU) coincides with the ...
QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its ...
MedPage Today on MSN
Thrombolysis No Better Than Aspirin for Central Retinal Artery Occlusion
Vision recovery similar at 30 days, consistent with other recent randomized studies ...
Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...
PPT1 is a recombinant protein used to treat an ultra-rare disease called Batten disease CLN1 for which there is ...
Shark Tank India's Namita Thapar recently shared a video of herself from her IV iron therapy. She talked about suffering from ...
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...
This is 40-something. Kim Kardashian, 45, has tried to cling to her youth by undergoing skin-tightening treatments, traveling ...
Company expects up to six-month review period per FDA guidelines New longer-term clinical data demonstrating durable positive brain biochemical ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results